Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
2.200
+0.750 (51.72%)
At close: Oct 31, 2025, 4:00 PM EST
2.520
+0.320 (14.55%)
Pre-market: Nov 3, 2025, 7:58 AM EST
RANI Employees
As of December 31, 2024, Rani Therapeutics Holdings had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees decreased by 34 or -24.29% compared to the previous year.
Employees
106
Change (1Y)
-34
Growth (1Y)
-24.29%
Revenue / Employee
$11,321
Profits / Employee
-$280,057
Market Cap
158.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106 | -34 | -24.29% |
| Dec 31, 2023 | 140 | -23 | -14.11% |
| Dec 31, 2022 | 163 | 49 | 42.98% |
| Dec 31, 2021 | 114 | 43 | 60.56% |
| Dec 31, 2020 | 71 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RANI News
- 4 days ago - Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - GlobeNewsWire
- 10 days ago - Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors - GlobeNewsWire
- 10 days ago - Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 13 days ago - Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai - Seeking Alpha
- 13 days ago - CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why - Invezz
- 17 days ago - Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma - Reuters
- 17 days ago - Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 17 days ago - Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing - GlobeNewsWire